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Inﬂammatory diseases are the result of complex and pathologically unbalanced multicel-
lular interactions. For decades, low-dose X-irradiation therapy (LD-RT) has been clinically
documented to exert an anti-inﬂammatory effect on benign diseases and chronic degen-
erative disorders. By contrast, experimental studies to conﬁrm the effectiveness and to
reveal underlying cellular and molecular mechanisms are still at their early stages. Dur-
ing the last decade, however, the modulation of a multitude of immunological processes
by LD-RT has been explored in vitro and in vivo. These include leukocyte/endothelial cell
adhesion, adhesion molecule and cytokine/chemokine expression, apoptosis induction,
and mononuclear/polymorphonuclear cell metabolism and activity. Interestingly, these
mechanisms display comparable dose dependences and dose-effect relationships with
a maximum effect in the range between 0.3 and 0.7Gy, already empirically identiﬁed to be
most effective in the clinical routine. This review summarizes data and models exploring
the mechanisms underlying the immunomodulatory properties of LD-RT that may serve as
a prerequisite for further systematic analyses to optimize low-dose irradiation procedures
in future clinical practice.
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INTRODUCTION
The relationship between ionizing radiation and an inﬂammatory
response displays a dichotomous character and greatly depends
on the radiation dose/quality and immune cell types investigated.
Whencomparedtoahighdoseexposurewithpronouncedinﬂam-
matory promoting effects (Williams et al.,2003),low-dose irradi-
ation (single doses 1.0Gy) reveals anti-inﬂammatory properties
(Seegenschmiedt et al., 2008; Rödel et al., 2012). This implicates
the involvement of complex mechanisms differentially operating
at different dose levels (Marples et al., 2004). Although low-dose
radiationtherapy(LD-RT)forthetreatmentof inﬂammatoryand
degenerative diseases (Seegenschmiedt et al., 2008) is successful
in clinical use since several decades, underlying immunological
and molecular mechanisms are far from being fully explored, in
partbecauseof theirunusualdiscontinuousdosedependencyand
non (DNA)-targeted properties. The present review focuses on
immunomodulatory properties of LD-RT to document the anti-
inﬂammatory efﬁcacy with special emphasis on preclinical in vivo
models.
CLINICAL APPLICATION OF LOW-DOSE RADIATION THERAPY
Theﬁrstknowndescriptionof theclinicalimplementationof LD-
RT to treat patients with non-cancerous diseases was as early as
1898whenSokoloffandStenbekreportedonpainreliefinpatients
with juvenile arthritis (Schmid-Monnard, 1898; Stenbek, 1898).
More than 100years later, a pattern of care study performed in
Germany was published with 37,410 patients treated for inﬂam-
matory diseases proving LD-RT to be an accepted conservative
treatment option at least in this country (Seegenschmiedt et al.,
2004). Concepts and doses in clinical practice have been estab-
lished empirically in the early twentieth century (von Pannewitz,
1933) recommending local treatment with single doses of 0.3–
1.0Gy in 4–5 fractions for acute and 1–3 fractions for chronic
inﬂammatory disorders adding to a total doses of 3–5Gy (acute)
and 12Gy (chronic), respectively (Seegenschmiedt et al., 2008).
Typical clinical indication comprise degenerative disorders like
rotator cuff syndrome (impingement of the shoulder joint), ten-
nis/golfer’s elbow (Epicondylopathia humeri), painful heel spur
(plantar fasciitis),exacerbated refractory,and painful osteoarthri-
tis, or hyper-proliferative syndromes like Dupytren’s disease or
the prevention of heterotopic ossiﬁcation (Seegenschmiedt et al.,
2004,2008).Concerningthemostclinicalrelevantendpointspain
relief, response, and analgetic effects, LD-RT is reported to result
in a 33–100%, a 47–100%, and a 12–89% efﬁcacy, respectively
(Kutzner et al., 2003; Micke and Seegenschmiedt, 2004; Niewald
et al., 2007; Adamietz et al., 2010; Betz et al., 2010; Heyd et al.,
2010).Moreover,duetothelow-dosesusedinactualclinicalprac-
tice, radiogenic acute or chronic side effects were not observed in
the treatment of inﬂammatory diseases (Seegenschmiedt et al.,
2008). By contrast, LD-RT is still considered unfashionable in
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some (Anglo-American) countries due to elder reports on harm-
ful side effects and increased mortality from leukemia and anemia
(Cannonetal.,1959;Court-BraunWm,1965).Nevertheless,non-
steroidal or steroidal drugs used as a pharmaceutical alternative
also display numerous side effects and a considerable number of
patients does not respond to the treatment (Rainsford, 2007).
Consequently, after improving radiation protection, LD-RT is
practised on an increasing number of patients as an effective and
safe treatment routine. To underscore this, a more recent pat-
tern of care study (Mücke et al., 2010) reported on 4.500 patients
with osteoarthritis of the knee receiving LD-RT demonstrating an
increased acceptance (95% referral) of this treatment alternative
in Germany.
PRINCIPLES OF INFLAMMATION
Inﬂammation comprises a complex and basic immunological
response to harmful stimuli, such as pathogens, damaged cells,
or irritants to remove the stimuli and to initiate a healing process.
Moreover, inﬂammation is a stereotyped response, and therefore
isconsideredtobeamechanismof innateimmunity,incontrastto
apathogenspeciﬁcadaptiveimmunity(Murphy,2011).Acascade
of biochemical events propagates and matures the inﬂammatory
response, involving the local vascular system. A pivotal molecu-
lar mechanism in the regulation of the inﬂammatory response
is the secretion of regulatory cytokines. Whereas interleukin-1
(IL-1) or tumor necrosis factor-a (TNF-a) activate cellular com-
ponents in a pro-inﬂammatory manner, anti-inﬂammatory pep-
tidesliketheisoformsof transforminggrowthfactorb(TGF-b1–3)
or IL-10 down regulate and thus limit the inﬂammatory cascade
(Mosmann, 1994).
Anearlyeventintheinﬂammatorycascadeistherecruitmentof
leukocytesfromperipheralbloodbyactivationoflocalendothelial
cells (ECs) with pro-inﬂammatory mediators mainly produced by
macrophages and dendritic cells (DCs) at the site of the damaged
tissue (Speyer and Ward, 2011). The subsequent effector phase of
inﬂammation is characterized by the accumulation of monocytes
and their differentiation into DCs or inﬂammatory macrophages
(Adams,1989).Thesecellssupportthelocalinﬂammatoryprocess
by a plethora of functions like phagocytosis, cytotoxicity, antigen
presentation, secretion of cytokines, and the production of nitric
oxide (NO), or reactive oxygen intermediates (Ding et al., 1988).
Inﬂammation can be further classiﬁed as either acute or chronic
(prolonged), characterized by a progressive shift in the type of
cells present at the site of inﬂammation and by simultaneous
destruction of the tissue from the inﬂammatory process.
MODULATORY PROPERTIES ON ENDOTHELIAL CELLS OF
LOW-DOSE IRRADIATION
As reported before, EC play a crucial role in the regulation of
the local inﬂammatory process both by their ability to recruit
leukocytes from peripheral blood and to express a variety of
cytokines/chemokines and growth factors (Speyer and Ward,
2011). As a consequence, the effect of low-dose irradiation on
the adhesion process was analyzed in in vitro assays using human
(EA.Hy926) or murine (mlEND1) EC and peripheral blood
mononuclear cells (PBMC). LD-RT prior to the stimulation by
TNF-a resulted in a hampered adhesion of PBMC to 43–50% of
the control level at 4 and 24h but elevated values at 12h after
irradiation with a single dose of 0.3–0.6Gy (Kern et al., 2000a;
Hildebrandt et al., 2002; Rödel et al., 2002). This characteristic
coincides with a biphasic kinetic and elevated expression of the
anti-inﬂammatory cytokine TGF-b1 both on the levels of mRNA
and protein in the same dose range. Moreover, abrogation of
TGF-b1 by neutralizing antibodies restored adhesion of PBMC
to irradiated EC (Rödel et al., 2004b), indicating the cytokine to
be a key player in the modulation of adhesion following low-dose
exposure.A hampered adhesion is further supported by a lowered
expression of the adhesion molecule E-selectin on stimulated EC
with a local minimum following a 0.3–0.5Gy exposure. This indi-
cates that the modulation of E-selectin may further contribute to
the anti-inﬂammatory properties of LD-RT (Hildebrandt et al.,
2002; Rödel et al., 2002).
MODULATORY PROPERTIES ON LEUKOCYTES OF LOW-DOSE
IRRADIATION
The major cellular elements of the immune system comprise dif-
ferent lineages of lymphocytes (B and T cells) as members of an
antigen-speciﬁc effector response, as well as polymorphonuclear
(PMN) and mononuclear leukocytes (PBMC) as components of
the innate immune system (Kobayashi et al., 2005). As outlined
below,these immune cells are modulated by distinct low-doses of
X-ray.
Apoptosis is a physiological endogenous cellular suicide pro-
gram mediated by a variety of endogenous and exogenous stimuli
including ionizing irradiation (Hengartner, 2000). Beside its cen-
tral role in cellular homeostasis, apoptosis signiﬁcantly impacts
on immune regulation and radiation response. In line with that,
cells undergoing apoptosis contribute to the modulation of acti-
vated mononuclear cell activity in a paradox manner by reducing
the secretion of pro-inﬂammatory cytokines like TNF-a or IL-
1. In addition, secretion of the anti-inﬂammatory peptide IL-10
is increased indicating an immune-suppressive potential of apop-
toticcells(Volletal.,1997).In1999,Kernetal.(1999)weretheﬁrst
toreportonadose-dependentdiscontinuousincreaseofapoptosis
inPBMCwithaplateauorpeakbetweena0.3and0.7Gyexposure.
Additionally,thecoincidenceof areducedPBMC/ECadhesion(as
reported before) and induction of apoptotic cell death in PBMC
prompted the group to investigate a putative link to the expres-
sion of adhesion molecules on the surface of the PBMC. They
describedatime-dependentproteolyticsheddingofL-selectinthat
was associated with their early apoptotic phenotype (Kern et al.,
2000b). More recently, a comparable performance of apoptosis
induction was reported for PMN irradiated 2h before stimula-
tionwithphorbolmyristateacetate(PMA).ApplyingsubG1DNA
content analyses, a discontinuous appearance of cell death was
observed, showing a relative maximum at 0.3Gy and a minimum
at 0.5Gy, respectively (Gaipl et al., 2009). Notably, the discontin-
uous course of apoptosis parallels a diminished protein level of
mitogenactivatedprotein(MAP)kinasesandproteinkinaseB(or
AKT), reported to be involved in the regulation of proliferation,
transcription, and apoptosis (Yang et al., 2004).
Neutrophilic PMN accumulation has been implicated in the
pathology of acute and chronic inﬂammatory diseases, such as
rheumatoid arthritis (Witko-Sarsat et al., 2000) in part by the
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secretion of chemotactic cytokines with the potential to amplify
leukocyteinﬁltration(Scapinietal.,2000).Thus,theimpactofLD-
RT on chemokine secretion in PMN was analyzed. In comparison
to CXCL8 and CCL18,CCL20 chemokine was shown to be exclu-
sivelyinducedinaTNF-adependentmannerbyacell–cellcontact
between PMN and EA.hy926 EC. Furthermore, irradiation with
dosesbetween0.5and1.0Gyresultedinadiscontinuousreduction
ofCCL20secretionthatparallelsahamperedPMNadhesiontoEC
with a pronounced effect at a 0.7Gy exposure (Rödel et al.,2008).
Very recently, Bauer et al. (2011) reported that monocytes are
severelyimpairedinbaseandDNAdouble-strandbreakrepairthat
renders them highly vulnerable to ROS and irradiation induced
cell death by apoptosis. Thus, it is tempting to assume that a
selective killing of monocytes at doses below 1Gy may cause a
depletionof macrophagesandDCsthatmayfurthercontributeto
the anti-inﬂammatory effects of LD-RT.
MODULATORY PROPERTIES ON MACROPHAGES AND DCS
OF LOW-DOSE IRRADIATION
Monocytes, unlike PMN, differentiate into tissue resident DCs
or macrophages (Adams, 1989). Due to their central role in the
initiation and the resolution of inﬂammatory processes, these
cells are considered as key players in the regulation of inﬂam-
mation (Valledor et al., 2010). Macrophages for example support
a local inﬂammatory process by a variety of functions including
phagocytosis,antigenpresentation,secretionof cytokines,andthe
expression of enzymes like inducible nitric oxide synthase (iNOS;
Fujiwara and Kobayashi, 2005). The latter enzyme processes the
synthesis of nitric oxide (NO) that in turn increases vascular
permeability and is involved in inﬂammatory pain (Holthusen,
1997; Abramson et al., 2001). In that context, low-dose radiation
(1.0Gy), if applied before stimulation with lipopolysaccharide
(LPS) and interferon-g (IFN-g) of murine RAW 264.7 cells (a
mouseleukemicmonocytemacrophageline)decreasesiNOSpro-
teinandNOproductionwithoutaffectingiNOSmRNAexpression
(Hildebrandt et al., 1998). This may indicate a translational or
post-translational regulation of the enzyme that is linked, at least
in part, to the analgetic properties of LD-RT.
Tsukimoto et al. further examined signal transduction path-
ways in RAW264.7 macrophage cells following g-irradiation
(137Cs source) with doses of 0.5–1.0Gy. Dephosphorylation of
both extracellular-signal-regulated kinases 1/2 (ERK1/2) and p38
mitogen activated protein kinase (MAPK) was observed at 15min
afterirradiationwhichwasconcomitantwithasigniﬁcantincrease
in the expression of the MAPK phosphatase-1 (MKP-1; Tsuki-
moto et al., 2009). Since activated p38 MAPK mediates pro-
inﬂammatory cytokine expression, they further assayed the effect
of low-dose radiation on TNF-a, showing that production of the
cytokine induced by LPS was signiﬁcantly suppressed in 0.5Gy
irradiated macrophages.
A further essential inﬂammatory cytokine is the IL-1 family
memberIL-1b,whichshowsnumerousactivitiesintheinﬂamma-
tory process (Dinarello, 2011). Using RAW264.7 macrophages, a
non-linearity in IL-1b production was observed after high-linear
energy transfer (LET) carbon ion radiation (Conrad et al., 2009).
Notably,ascomparedtootherinﬂammatorycytokines,expression
of IL-1b is tightly regulated by a three step process and requires
two distinct stimuli (Tschopp et al., 2003). In more recent studies
using human THP-1 derived macrophages which were stimulated
by LPS and MSU (mono sodium urate crystals) a signiﬁcantly
decreased IL-1b secretion at doses of 0.5 and 0.7Gy was con-
ﬁrmed by Lödermann et al. (2012). In their experiments, the
IL-1b machinery (also called the NALP3 inﬂammasome) was not
affected by the doses used, but a hampered secretion of the IL-1b
correlates with a reduction in nuclear translocation of the tran-
scription factor nuclear factor kB (NF-kB) subunit RelA (p65) in
line with a decreased protein amount of upstream (p38 MAPK)
and downstream molecules (AKT). Thus it is tempting to con-
clude,thatthediscontinuousregulationof IL-1bfollowingLD-RT
may occur in a NF-kB dependent manner.
Furthermore,activatedmacrophagesareamajorsourceofreac-
tive oxygen species (ROS) when they mount an oxidative burst to
destroy pathogens. Accordingly, the impact of low-dose irradia-
tion on oxidative burst activity and superoxide production was
investigated in RAW 264.7 macrophages after stimulation with
TNF-a/IFNg, PMA, or the yeast product zymosan. Low X-ray
doses between 0.3 and 0.6Gy signiﬁcantly reduced the oxidative
burst in these activated macrophages, whereas higher doses had
little effect. This indicates that a diminished release of ROS may
contribute to the local therapeutic effect of LD-RT (Schaue et al.,
2002).
Finally, Jahns et al. recently analyzed the effect of LD-RT on
the maturation,cytokine release,and T-Lymphocyte activation of
human DCs. They indicated that irradiation of DC-precursors
in vitro does not inﬂuence surface marker (CD80, CD83, CD86)
expression or cytokine proﬁle of immature DCs nor of mature
DCs stimulated by LPS,neither did it inﬂuence the capacity of the
DCs to stimulate T-cell proliferation (Jahns et al., 2011).
MODULATION OF TRANSCRIPTION FACTOR ACTIVITY BY
LOW-DOSE IRRADIATION
As there is enormous evidence for the involvement of cellular
transcription factors including TP53, activating protein 1 (AP-1),
and NF-kB in both,cellular radiation response and inﬂammation
(Habraken and Piette, 2006), they may also represent a crucial
link between low-dose radiation and their immune modulatory
properties. The family of NF-kB transcription factors comprises a
heterogeneous group of homo- or heterodimeric members of the
Relfamilyincludingp50,p52,p65/RelA,c-Rel,andRelB(Baeuerle
and Baltimore, 1996; Oeckinghaus et al., 2011). NF-kB is located
in the cytoplasm in an inactive form by binding to inhibitor mol-
ecules of the IkB family (IkBa, IkBb, IkBg/NEMO, IkB+, p100,
and p105; Huxford and Ghosh, 2009). Upon dissociation of the
inhibitors, NF-kB dimers translocate into the nucleus and bind
speciﬁc sequence elements in the enhancer/promoter regions of
a variety of effector genes. These include factors implicated in
DNA damage repair, the execution, or inhibition of cell death
by apoptosis (Oeckinghaus et al., 2011) and cytokines (e.g., IL-1,
TNF-a), adhesion molecules (e.g., E-selectin), and enzymes (e.g.,
iNOS) essential in the regulation of the immune system (Kracht
and Saklatvala, 2002). In the ﬁeld of low-dose irradiation, Prasad
et al. (1994) were the ﬁrst to report on an activation of NF-kB in
a discontinuous manner with peak activities at 8 and 36h after
irradiation analyzed in 244B lymphoblastoid and B16 melanoma
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cells. In accordance to these ﬁndings, a comparable time depen-
denceofDNAbindingandtranscriptionalactivitywithaﬁrstpeak
at 4h and a second peak at 24–30h was conﬁrmed in stimulated
human EA.Hy926 EC (Rödel et al., 2004a). Based on these initial
observations, factors engaged in the pathway(s) of NF-kB activa-
tion in stimulated EA.Hy926 EC were investigated. Among these
regulatory proteins, X chromosome-linked inhibitor of apoptosis
protein (XIAP) that enhances RelA/p65 nuclear translocation and
promotes the degradation of IkB (Hofer-Warbinek et al., 2000;
Jin et al., 2009) was investigated in more detail. Following irra-
diation, a discontinuous proﬁle of XIAP-expression was observed
with a relative maximum at 0.5 and 3.0Gy which parallels a dis-
continuity in NF-kB induction. Furthermore, RNA-interference
(siRNA) derived knockdown of XIAP resulted in a hampered
NF-kB transcriptional activity, indicating a regulatory interrela-
tionship between these factors (Rödel et al.,2010). These ﬁndings
are in agreement with the observation that XIAP interacts with
MAP Kinase Kinase 2 (MEKK2). The latter has previously been
shown to be associated with a second wave NF-kB activation
and the propagation of inﬂammatory processes (Winsauer et al.,
2008). Moreover, a functional consequence of XIAP-expression
and altered NF-kB activity on the adhesion process was obvi-
ous since XIAP attenuation showed an abrogation of the reduced
PBMC binding normally observed following a 0.5Gy exposure.
This effect is, at least in part, driven by a reduced secretion of the
cytokine TGF-b1, a key player in the anti-inﬂammatory effects of
low-dose irradiation (Rödel et al., 2007).
Membersof thec-Fosandc-Junproteinfamilythatcollectively
form the homo- or heterodimeric AP-1 complex (Criswell et al.,
2003),are considered to be involved in the transcription of a vari-
ety of immune effector molecules,including TGF-b1. By applying
electrophoretic mobility shift assays (EMSA) and luciferase based
transcriptional activity assays, a biphasic induction of AP-1 was
detected in EA.Hy 926 EC (Rödel et al., 2009) that may further
contribute to the immunomodulatory properties of LD-RT.
MECHANISMS UNDERLYING A DISCONTINUOUS
CHARACTERISTIC OF LOW-DOSE IRRADIATION EFFECTS
The classical paradigm of radiation biology is based on the con-
cept, that deposition of energy to the nucleus and the resulting
DNA damage is responsible for the biological consequences of
radiation exposure. By contrast, based on recent ﬁndings, there is
growing evidence for non-(DNA) targeted effects that challenged
this classical concept. Among these ﬁndings bystander or distant
out of ﬁeld (abscopal) mechanisms, as well as adaptive responses
have been reported (Mothersill and Seymour, 2006; Hildebrandt,
2010). Notably, these novel concepts also take into consideration
a complex intercellular communication and describe radiation
responses on a tissue level (Barcellos-Hoff, 2005). The molecu-
lar mechanisms responsible for the discontinuous dose response
characteristics, a common hallmark of these non-targeted effects,
remain elusive at present and most likely originate from an over-
lap of several processes that may be initiated at various thresholds
and operate in a staggered manner. There may also be paral-
lels to the phenomenon of low-dose hyper-radiosensitivity and
induced radioresistance, which have been reported for cellular
survival at doses below 0.3Gy and in the dose range of 0.3–
0.6Gy (Joiner et al., 2001; Marples and Collis, 2008). The current
hypothesis on the regulation of this behavior is that the HRS
region(<0.3Gy)reﬂectsanareaofincreasedinductionofapopto-
sis in cells that failed to undergo an ataxia telangiectasia-mutated
(ATM)-dependent G2-phase cell cycle arrest. By contrast, a tran-
sition to induced radioresistance originates from a shift toward
a G2-checkpoint induction, giving time for repair of DNA dam-
age, and to increase cell survival. Corresponding to this, DNA
double-strand breaks induced after very low-dose irradiation do
not seem to be repaired, and cells containing residual dam-
age were removed by a TP53-dependent apoptosis (Rothkamm
and Löbrich, 2003). Interestingly, two seminal molecular studies
(Xu et al., 2002; Bakkenist and Kastan, 2003) have shown dis-
continuous responses over the 0.1–1.0Gy dose range, the most
important being the activation and (auto)phosphorylation of the
DNA damage sensor ATM. Once activated, ATM is implicated in
several signaling cascades and is essential for the regulation of
a cell cycle arrest, DNA damage repair, and acts as an inducer
of the ATM–IkK–NF-kB signaling pathway (Hacker and Karin,
2006).
Based on these ﬁndings, it is reasonable to assume that beside
DNA (repair)-mediated mechanisms, a non-linear dose-effect
relationship may be associated with a differential protein expres-
sion.Inlinewiththat,Pluderandcolleaguesrecentlyreportedthat
exposure to Co60 g-rays of EA.hy926 EC resulted in rapid change
in the cytoplasmic proteome. The group identiﬁed 15 signiﬁ-
cantly differentially expressed proteins of which 10 were up- and
5 down-regulated. Pathways inﬂuenced by the factors include the
RhoA pathway,fatty acid metabolism,and cellular stress response
(Pluder et al., 2011).
ANTI-INFLAMMATORY PROPERTIES IN PRECLINICAL
MODELS OF LD-RT
Beside an increasing knowledge concerning underlying mecha-
nisms, in vivo models of experimentally induced arthritis (Gilroy
et al., 1998) have been established to investigate a clinical anti-
inﬂammatory efﬁcacy of LD-RT. In 1933 von Pannewitz (1933)
reported on a ﬁrst series of animal studies, when rabbits with
electro-coagulation of the knee joint cartilage or by mechanical
bone destruction were treated with 1.0Gy single dose irradia-
tion. This treatment does not show a beneﬁt on the degenerative
changes,however,animprovementof thesymptomsjointswelling
(anindicatorof reducedinﬂammation)andpainwasobserved.In
subsequent years a variety of inducible models have been estab-
lished to more closely mimic the situation in joints of patients
suffering from rheumatoid arthritis (Smolen and Steiner, 2003).
Experimental induction of arthritis in rodents treated either with
zymosan(ayeastproduct)orinactivatedmycobacteriumtubercu-
losis(mtb)resultsinafast(ﬁvedaysfrominjection)jointswelling
associated with cartilage destruction and bone loss (Asquith et al.,
2009). Using an intra-articular injection of papain, inactivated
mtb or zymosan, Budras et al., Trott et al., and Fischer et al.
induced an acute arthritis in rabbit knees. In their experiments
ﬁve weekly fractions of 1.5 or 1.0Gy signiﬁcantly diminished the
inﬂammatoryproliferationofthesynovialcovercells,thesynthesis
of synovialﬂuid,andthusswellingof thejoint(Budrasetal.,1986;
Trottetal.,1995;Fischeretal.,1998).Althoughpartiallynotreach-
ing a level of signiﬁcance, morphometric data further revealed a
decreased number of the synovial cell layers and thus thickness of
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thesynovialmembraneandalowereddistancebetweencapillaries
and synovial membranes following irradiation.
TheeffectsofLD-RTonmorphologicalprogressionofadjuvant
induced arthritis in rats were further investigated by Hildebrandt
et al. In their analysis, local irradiation of the arthritic joints
reducedclinicalsymptoms,ifgivenatdays15–19afterinductionof
arthritisbyintradermalinjectionof mtb.Histopathologicalanaly-
sis performed at days 21 and 30 revealed a signiﬁcant reduction of
cartilageandbonedestructionwithminimaleffectonthenumber
ofinﬂammatorycellsintheperiarticulartissue(Hildebrandtetal.,
2000). In addition, the histologically observed prevention of dis-
easeprogressionappearstoberelatedtoamodulationof theiNOS
activity with a reduction of the histochemical iNOS score and
increase of heme oxygenase-1 (HO-1) expression (Hildebrandt
et al., 2003).
Most of the analyses as reported before, however, used single
fractions that exceed a dose of 1.0Gy. In order to explore the low-
est effective dose, the optimal time of treatment and the most
favorable schedule, the effect of different fractionation schemes
was analyzed by Liebmann et al. The most pronounced treatment
effectwasobservedaftertwodailyfractionatedseriesof 50.5Gy
with an early treatment onset (days 10–14) and repetition after an
interval of 8days (days 22–26; Liebmann et al., 2004).
Relevantly, a variety of mechanisms, recognized in in vitro
investigations to contribute to the immunomodulatory proper-
ties of LD-RT, were conﬁrmed in the in vivo situation. Using an
air pouch model in NMRI mice, the expression of TNF-a, IL-
1b, and the proteins iNOS, HO-1, cyclooxygenase-2 (Cox2), and
heat shock protein 70 (Hsp70) were investigated. Whereas the
amount of exudates and number of inﬂammatory cells mainly
remained unaffected, iNOS expression was decreased by irradi-
ation concomitant with an increased expression of Hsp70 and
HO-1(Schaueetal.,2005).Inaddition,asbindingof lymphocytes
to blood vessel EC is crucial to drive an inﬂammatory process,the
impact of LD-RT on adhesion and extravasation was analyzed by
intra-vitalmicroscopyinmicestimulatedwithLPS.Inaccordance
to the in vitro ﬁndings, leukocyte adhesion in intestinal venules
was diminished after irradiation with 0.1, 0.3, and 0.6Gy, respec-
tively (Arenas et al., 2006). This mechanistically correlated with
increased levels of TGF-b1 in the serum of the mice, and partially
could be restored by neutralization of the cytokine.
In a model of collagen inducible arthritis (CIA), DBA/1J mice
were irradiated once before induction and on consecutive 4weeks
with a single dose of 0.5Gy. The authors described a signiﬁcant
improvement of the clinical symptoms associated with a reduced
amount of antitype II collagen antibodies and reduced values of
inﬂammatory cytokines TNF-a, IFN-g, and IL-6 in the serum of
treated mice (Nakatsukasa et al., 2008). In proceeding analyses,
the group further reported on a signiﬁcant increased propor-
tion of CD4(C)CD25(C)FoxP3(C) regulatory (Treg) cells in the
spleen of irradiated mice at 4, 6, and 8weeks after immunization
with collagen and a hampered secretion of inﬂammatory IL-17
and IL-6 (Nakatsukasa et al., 2010). Tregs in turn are reported to
act as suppressors of osteoclast cell activity, which drive arthritis
and bone loss and therefore may contribute to the reduction of
the clinical symptoms in mice treated with low-dose irradiation
(Zaissetal.,2010).Inaccordancetotheseobservations,Wengetal.
(2010) reported that a therapeutic effect of low-dose irradiation
was associated with an increment in the proportion of Treg cells
despite the overall reduction in lymphocyte count. By contrast,
depletion of CD25 or folate receptor (FR)4(C) cells with speciﬁc
antibodies before the treatment abolished the beneﬁcial effects of
irradiation conﬁrming a fundamental role of Treg.
The models mentioned beforehand, however, suffer from the
fact of an artiﬁcial induction of pathologic conditions in for-
mer healthy animals, that does in detail not reﬂect the situation
in arthritic patients which are suffering from the disease since
years and display an autoimmune status (Imboden, 2009). To
overcome these limitations,Frey et al. (2009) were the ﬁrst to ana-
lyze effects of low-dose irradiation in human TNF-a transgenic
(hTNFtg) mice (Frey et al., 2009). These animals overexpress the
cytokine TNF-a during their whole lifetime and develop a geneti-
cally determined polyarthritis (PA), with an onset after 3–6weeks
of age (beginning PA). The disease pattern in animals shows sim-
ilarity to a human rheumatoid arthritis such as joint swelling
and deformation, synovial inﬂammation, cartilage damage, and
bone erosion, and is fully blown at an age of 9–12weeks (Kef-
fer et al., 1991). Irradiation of these mice with ﬁve times 0.5Gy
at a beginning (4–6weeks) PA demonstrates signiﬁcantly tempo-
ral improved clinical symptoms like a reduced paw swelling and
increased grip strength. Those effects are less pronounced at later
stages of the disease (9–12weeks, fully established PA; Frey et al.,
2009).
More insight on the impact of low-dose irradiation further
arises from experiments on genetically determined MRL-lpr/lpr
mouse autoimmune diseases. These animals are characterized by
a deletion in the TNF receptor superfamily member six (FAS)
gene resulting in an impaired apoptosis of autoreactive lympho-
cytes and aberrant T cell proliferation, concomitant with massive
autoantibody production, immune complex glomerulonephritis,
and arthritis. If irradiated with a daily single dose of 0.5Gy for
4weeks to a total dose of 10Gy the mass of the spleen of the
MRL-lpr/lpr mice was signiﬁcantly reduced in line with a dras-
tically reduced amount of CD3(C)CD4( )CD8( )B220(C) T
cells, which drive the splenomegaly (Tago et al., 2008). In an
additionalmodelof experimentalautoimmuneencephalomyelitis
(EAE) animals were irradiated with a total dose of 5.5Gy, sub-
divided in 0.5Gy fractions over 5weeks (one fraction before
induction and four fractions once a week for 4weeks) resulting
in a reduced EAE incidence along with a signiﬁcant improved
clinical score and delayed onset of pathological changes (Tsuki-
motoetal.,2008).Theseeffectsmayarisefromahamperedability
of spleenocytes to produce the pro-inﬂammatory cytokines IL-6,
and IL-17. Furthermore, irradiated mice spleenocytes exhibited a
reduced IFN-g secretion and shifted the Th1/Th2 balance to an
anti-inﬂammatory phenotype.
In summary, in vivo data and models clearly conﬁrmed anti-
inﬂammatory effects and have proven true a variety of immune
modulatory effects of low-dose irradiation as summarized in
Table 1. They may display suitable platforms for an intensiﬁed
researchof theunderlyingmechanismsandonoptionstoimprove
the clinical efﬁcacy of LD-RT.
CONCLUSION
Considerable progress has recently been achieved in the under-
standing of cellular targets and molecular mechanisms involved
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FIGURE 1 |Actual model on the modulation of inﬂammatory cell activity
and factors involved in the anti-inﬂammatory effect of LD-RT (<1Gy).
Irradiation resulted in a hampered adhesion of peripheral blood mononuclear
cells (PBMC) to the endothelium, due to the secretion of the
anti-inﬂammatory cytokine transforming growth factor b1 (TGF-b1), a
decreased expression of E-selectin on the surfaces of endothelial cells, a local
increase of apoptosis, and the proteolytic shedding of L-selectin from PBMC.
In stimulated macrophages a diminished activity of the inducible nitric oxide
synthase (iNOS) in line with reduced levels of nitric oxide (NO), a lowered
production of reactive oxygen species (ROS), and a diminished secretion of
interleukin-1b (IL-1b) and tumor necrosis factor-a (TNF-a) may contribute to
local anti-inﬂammatory effects. Moreover, polymorphonuclear cells (PMN)
respond to low-dose exposure with a locally increased rate of apoptosis, a
hampered secretion of CCL20 chemokine and alterations in signal
transduction pathways p38 mitogen activated protein kinase (MAPK) and
protein kinase B (AKT).
in the immune modulatory properties of low-dose irradiation
as depicted in Figure 1. However, as (chronic) inﬂam-
matory and degenerative diseases are based upon complex
(patho)physiological networks, a variety of yet unresolved ques-
tions exists. Thus, intensive translational and clinical research
efforts as well as the development of further basic models are
seriously needed to recognize additional contributing factors and
mechanisms. Moreover, on-going efforts should also focus on
a putative relationship to tumor immune biology to optimize
clinical use of radiation therapy of both benign and malignant
diseases.
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